Thoratec Corp (THOR) 63.06 $THOR
St. Jude to Acquire Thoratec for $3.4B: Potent Combination? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 2 hrs 41 mins ago
St. Jude Medical (STJ) is set to acquire HeartMate maker Thoratec Corp.
STJ: 75.53 (-1.14), THOR: 63.06 (-0.40), AGIO: 118.42 (+1.04), RMTI: 15.99 (-0.74)
Thoratec Stockholders Encouraged to Contact Securities Law Firm about Takeover
PR Newswire - Thu Jul 23, 12:28PM CDT
Securities lawyers at Dunnam & Dunnam are investigating the board of Thoratec (NASDAQ: THOR) in connection with a buyout for only $63.50 per share. Concerned THOR investors are encouraged to contact attorney Hamilton Lindley by clicking here.
THOR: 63.06 (-0.40)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Thoratec Corp. of Commencement of an Investigation Concerning the Fairness of the Sale of the Company to St. Jude Medical, Inc. - THOR
PR Newswire - Thu Jul 23, 11:58AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
STJ: 75.53 (-1.14), THOR: 63.06 (-0.40)
SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Thoratec Corp. And Encourages Investors To Contact The Firm For Additional Information
Business Wire - Thu Jul 23, 10:55AM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Thoratec Corp. ("Thoratec" or the "Company"
(NasdaqGS: THOR) relating to the proposed buyout of the Company by St. Jude Medical Inc.
THOR: 63.06 (-0.40)
Breakout Watch: Abiomed Pumps Up Before Earnings
at Investor's Business Daily - Thu Jul 23, 10:39AM CDT
Heart pump maker Abiomed (ABMD) is closing in on a buy point as it gets ready to report Q2 earnings Aug. 4. With a mission of "recovering hearts and saving lives," Abiomed developed the Impella 2.5, which it bills as the world's smallest heart pump....
ABMD: 73.19 (-1.99), MDT: 76.80 (-0.02), STJ: 75.53 (-1.14), EW: 156.25 (-0.47), THOR: 63.06 (-0.40)
THORATEC CORP. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to St. Jude Medical Inc.
Business Wire - Thu Jul 23, 10:14AM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Thoratec Corp. ("Thoratec" (NasdaqGS: THOR) concerning the sale to St. Jude Medical Inc. Under the terms of the agreement, Thoratec shareholders will only receive $63.50 in cash for each share owned, which is virtually no premium over the 52-week high and the closing price before the deal was announced.
STJ: 75.53 (-1.14), THOR: 63.06 (-0.40)
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Thoratec Corporation Stockholders
Business Wire - Wed Jul 22, 4:30PM CDT
Kirby McInerney LLP is investigating potential claims against the Board of Directors of Thoratec Corporation ("Thoratec" or the "Company" (NASDAQ:THOR) concerning the proposed acquisition of the Company by St. Jude Medical, Inc. Pursuant to the terms of the definitive agreement, Thoratec stockholders will receive $63.50 in cash for each share of Thoratec common stock they own, in a transaction valued at approximately $3.4 billion.
THOR: 63.06 (-0.40)
Morgan & Morgan Announces the Investigation of Thoratec Corp. - THOR
PR Newswire - Wed Jul 22, 3:26PM CDT
Morgan & Morgan announces that it is investigating the Board of Directors of Thoratec Corp. ("Thoratec" or the "Company" (THOR) for possible breaches of fiduciary duty and other violations of law in connection with the sale of the company to St. Jude Medical Inc. (STJ).
STJ: 75.53 (-1.14), THOR: 63.06 (-0.40)
Apple's Fall Takes a Big Bite Out of Market Indexes
at The Street - Wed Jul 22, 3:08PM CDT
Apple's tumble pressured markets on Wednesday, punishing benchmark indexes in a post-earnings slump.
GPRO: 63.95 (+2.27), BRCM: 52.30 (+0.54), FB: 95.44 (-1.60), HAL: 42.33 (+0.79), BA: 146.11 (-0.36), NFLX: 110.10 (-1.40), YHOO: 39.21 (-0.03), LNKD: 224.10 (-0.70), IBM: 161.73 (+1.38), CMG: 725.94 (+0.12), STJ: 75.53 (-1.14), XLK: 42.59 (-0.09), THOR: 63.06 (-0.40), MSFT: 46.11 (+0.57), AAPL: 125.16 (-0.06), BHI: 59.26 (+0.98)
Harwood Feffer LLP Announces Investigation of Thoratec Corporation
PR Newswire - Wed Jul 22, 2:54PM CDT
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Thoratec Corporation ("Thoratec" or the "Company" (NASDAQ: THOR) concerning the proposed acquisition of the Company by SJM International, Inc. and St. Jude Medical, Inc. (collectively, "St. Jude" (NYSE: STJ).
STJ: 75.53 (-1.14), THOR: 63.06 (-0.40)
WeissLaw LLP: Thoratec Corporation Acquisition By St. Jude Medical May Not Be In The Best Interest Of THOR Shareholders
PR Newswire - Wed Jul 22, 2:00PM CDT
The fairness of the proposed acquisition of Thoratec Corporation ("THOR" or the "Company" by St. Jude Medical ("St. Jude" is the subject of an investigation by WeissLaw LLP, a national class action, shareholder rights law firm. The investigation is focusing on possible breaches of fiduciary duty and other violations of law by the Board of Directors of THOR for agreeing to sell the Company to St. Jude. On July 22, 2015, the Company announced it had reached a definitive agreement for St. Jude to acquire THOR in a transaction valued at approximately $3.4 billion. Under the terms of the agreement, THOR shareholders will receive $63.50 in cash for each THOR share they own. WeissLaw is investigating whether THOR's Board acted to maximize shareholder value prior to entering into the agreement.
STJ: 75.53 (-1.14), THOR: 63.06 (-0.40)
Stocks Slip as Crude Oil Settles Below $50
at The Street - Wed Jul 22, 1:57PM CDT
Stocks remain in the red on Wednesday as crude oil closes below $50, its lowest level since April 2.
GPRO: 63.95 (+2.27), BRCM: 52.30 (+0.54), FB: 95.44 (-1.60), HAL: 42.33 (+0.79), BA: 146.11 (-0.36), NFLX: 110.10 (-1.40), YHOO: 39.21 (-0.03), LNKD: 224.10 (-0.70), IBM: 161.73 (+1.38), CMG: 725.94 (+0.12), STJ: 75.53 (-1.14), XLK: 42.59 (-0.09), THOR: 63.06 (-0.40), MSFT: 46.11 (+0.57), AAPL: 125.16 (-0.06), BHI: 59.26 (+0.98)
Robbins Arroyo LLP: Acquisition of Thoratec Corp. (THOR) by St. Jude Medical, Inc. (STJ) May Not Be in Shareholders' Best Interests
PR Newswire - Wed Jul 22, 1:21PM CDT
Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of Thoratec Corp. (NASDAQ: THOR) by St. Jude Medical, Inc. (NYSE: STJ). On July 22, 2015, the two companies announced the signing of a definitive merger agreement pursuant to which St. Jude will acquire Thoratec. Under the terms of the agreement, Thoratec shareholders will receive $63.50 for each share of Thoratec common stock.
STJ: 75.53 (-1.14), THOR: 63.06 (-0.40)
EQUITY ALERT: The Rosen Law Firm Announces Investigation of Thoratec Corp. Concerning its Proposed Sale to St. Jude Medical Inc. - THOR
Business Wire - Wed Jul 22, 12:23PM CDT
The Rosen Law Firm, a global investor rights law firm, announces that it is investigating the Board of Directors of Thoratec Corp. (NASDAQ: THOR) for possible breaches of fiduciary duty and other violations of law by failing to adequately shop Thoratec to maximize shareholder value before agreeing to be acquired by St. Jude Medical Inc. (NASDAQ: STJ).
STJ: 75.53 (-1.14), THOR: 63.06 (-0.40)
Why Thoratec Corp.'s Shares Jumped Today
George Budwell, The Motley Fool - Motley Fool - Wed Jul 22, 11:41AM CDT
What : Shares of the medical device-maker for heart failure Thoratec rose by 10% today on exceptional volume after the company announced that it has agreed to a $3.4 billion buyout offer from St. Jude Medical . Digging into the details, St. Jude...
STJ: 75.53 (-1.14), THOR: 63.06 (-0.40)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Thoratec Corp. of Commencement of an Investigation Concerning the Fairness of the Sale of the Company to St. Jude Medical, Inc.
Business Wire - Wed Jul 22, 10:23AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
STJ: 75.53 (-1.14), THOR: 63.06 (-0.40)
Stocks Fall Back as Crude Oil Dips Below $50
at The Street - Wed Jul 22, 9:53AM CDT
Stocks return to near session lows on Wednesday morning as crude oil dips below $50 a barrel on the back of a rise in weekly inventories.
KO: 40.84 (-0.06), GPRO: 63.95 (+2.27), BA: 146.11 (-0.36), T: 33.93 (-0.34), YHOO: 39.21 (-0.03), CMG: 725.94 (+0.12), DTV: 92.19 (-0.64), STJ: 75.53 (-1.14), THOR: 63.06 (-0.40), MSFT: 46.11 (+0.57), AAPL: 125.16 (-0.06)
St. Jude Medical Nabs Thoratec, Beats Q2 Estimates
at Investor's Business Daily - Wed Jul 22, 9:28AM CDT
Device giant St. Jude Medical (STJ) on Wednesday beat Q2 estimates and announced that it's acquiring Thoratec (THOR) for $3.4 billion, sending the latter's stock to a new high. Rumors that St. Jude and Thoratec were talking drove Thoratec's stock up...
STJ: 75.53 (-1.14), THOR: 63.06 (-0.40), HTWR: 85.63 (-2.58)
Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Thoratec Corporation Concerning its Proposed Sale to St. Jude Medical Inc.
PR Newswire - Wed Jul 22, 9:26AM CDT
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against the Board of Directors of Thoratec Corporation ("Thoratec" or the "Company" (NasdaqGS:THOR) related to the proposed acquisition of the Company by St. Jude Medical Inc. The transaction is valued at around $3.4 Billion or $63.50 per share.
STJ: 75.53 (-1.14), THOR: 63.06 (-0.40)
St. Jude Tops Q2 Earnings, Sales; Set to Acquire Thoratec - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 22, 9:17AM CDT
St. Jude Medical Inc (STJ) reported adjusted earnings of $1.03 in second-quarter 2015 which beat the Zacks Consensus Estimate by 4 cents.
STJ: 75.53 (-1.14), THOR: 63.06 (-0.40), RMTI: 15.99 (-0.74), NUVA: 49.64 (+0.05)
St. Jude to Acquire Thoratec for $3.4B: Potent Combination? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 2 hrs 41 mins ago
St. Jude Medical (STJ) is set to acquire HeartMate maker Thoratec Corp.
STJ: 75.53 (-1.14), THOR: 63.06 (-0.40), AGIO: 118.42 (+1.04), RMTI: 15.99 (-0.74)
Thoratec Stockholders Encouraged to Contact Securities Law Firm about Takeover
PR Newswire - Thu Jul 23, 12:28PM CDT
Securities lawyers at Dunnam & Dunnam are investigating the board of Thoratec (NASDAQ: THOR) in connection with a buyout for only $63.50 per share. Concerned THOR investors are encouraged to contact attorney Hamilton Lindley by clicking here.
THOR: 63.06 (-0.40)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Thoratec Corp. of Commencement of an Investigation Concerning the Fairness of the Sale of the Company to St. Jude Medical, Inc. - THOR
PR Newswire - Thu Jul 23, 11:58AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
STJ: 75.53 (-1.14), THOR: 63.06 (-0.40)
SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Thoratec Corp. And Encourages Investors To Contact The Firm For Additional Information
Business Wire - Thu Jul 23, 10:55AM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Thoratec Corp. ("Thoratec" or the "Company"
(NasdaqGS: THOR) relating to the proposed buyout of the Company by St. Jude Medical Inc. THOR: 63.06 (-0.40)
Breakout Watch: Abiomed Pumps Up Before Earnings
at Investor's Business Daily - Thu Jul 23, 10:39AM CDT
Heart pump maker Abiomed (ABMD) is closing in on a buy point as it gets ready to report Q2 earnings Aug. 4. With a mission of "recovering hearts and saving lives," Abiomed developed the Impella 2.5, which it bills as the world's smallest heart pump....
ABMD: 73.19 (-1.99), MDT: 76.80 (-0.02), STJ: 75.53 (-1.14), EW: 156.25 (-0.47), THOR: 63.06 (-0.40)
THORATEC CORP. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to St. Jude Medical Inc.
Business Wire - Thu Jul 23, 10:14AM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Thoratec Corp. ("Thoratec"
(NasdaqGS: THOR) concerning the sale to St. Jude Medical Inc. Under the terms of the agreement, Thoratec shareholders will only receive $63.50 in cash for each share owned, which is virtually no premium over the 52-week high and the closing price before the deal was announced. STJ: 75.53 (-1.14), THOR: 63.06 (-0.40)
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Thoratec Corporation Stockholders
Business Wire - Wed Jul 22, 4:30PM CDT
Kirby McInerney LLP is investigating potential claims against the Board of Directors of Thoratec Corporation ("Thoratec" or the "Company"
(NASDAQ:THOR) concerning the proposed acquisition of the Company by St. Jude Medical, Inc. Pursuant to the terms of the definitive agreement, Thoratec stockholders will receive $63.50 in cash for each share of Thoratec common stock they own, in a transaction valued at approximately $3.4 billion. THOR: 63.06 (-0.40)
Morgan & Morgan Announces the Investigation of Thoratec Corp. - THOR
PR Newswire - Wed Jul 22, 3:26PM CDT
Morgan & Morgan announces that it is investigating the Board of Directors of Thoratec Corp. ("Thoratec" or the "Company"
(THOR) for possible breaches of fiduciary duty and other violations of law in connection with the sale of the company to St. Jude Medical Inc. (STJ). STJ: 75.53 (-1.14), THOR: 63.06 (-0.40)
Apple's Fall Takes a Big Bite Out of Market Indexes
at The Street - Wed Jul 22, 3:08PM CDT
Apple's tumble pressured markets on Wednesday, punishing benchmark indexes in a post-earnings slump.
GPRO: 63.95 (+2.27), BRCM: 52.30 (+0.54), FB: 95.44 (-1.60), HAL: 42.33 (+0.79), BA: 146.11 (-0.36), NFLX: 110.10 (-1.40), YHOO: 39.21 (-0.03), LNKD: 224.10 (-0.70), IBM: 161.73 (+1.38), CMG: 725.94 (+0.12), STJ: 75.53 (-1.14), XLK: 42.59 (-0.09), THOR: 63.06 (-0.40), MSFT: 46.11 (+0.57), AAPL: 125.16 (-0.06), BHI: 59.26 (+0.98)
Harwood Feffer LLP Announces Investigation of Thoratec Corporation
PR Newswire - Wed Jul 22, 2:54PM CDT
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Thoratec Corporation ("Thoratec" or the "Company"
(NASDAQ: THOR) concerning the proposed acquisition of the Company by SJM International, Inc. and St. Jude Medical, Inc. (collectively, "St. Jude" (NYSE: STJ). STJ: 75.53 (-1.14), THOR: 63.06 (-0.40)
WeissLaw LLP: Thoratec Corporation Acquisition By St. Jude Medical May Not Be In The Best Interest Of THOR Shareholders
PR Newswire - Wed Jul 22, 2:00PM CDT
The fairness of the proposed acquisition of Thoratec Corporation ("THOR" or the "Company"
by St. Jude Medical ("St. Jude" is the subject of an investigation by WeissLaw LLP, a national class action, shareholder rights law firm. The investigation is focusing on possible breaches of fiduciary duty and other violations of law by the Board of Directors of THOR for agreeing to sell the Company to St. Jude. On July 22, 2015, the Company announced it had reached a definitive agreement for St. Jude to acquire THOR in a transaction valued at approximately $3.4 billion. Under the terms of the agreement, THOR shareholders will receive $63.50 in cash for each THOR share they own. WeissLaw is investigating whether THOR's Board acted to maximize shareholder value prior to entering into the agreement. STJ: 75.53 (-1.14), THOR: 63.06 (-0.40)
Stocks Slip as Crude Oil Settles Below $50
at The Street - Wed Jul 22, 1:57PM CDT
Stocks remain in the red on Wednesday as crude oil closes below $50, its lowest level since April 2.
GPRO: 63.95 (+2.27), BRCM: 52.30 (+0.54), FB: 95.44 (-1.60), HAL: 42.33 (+0.79), BA: 146.11 (-0.36), NFLX: 110.10 (-1.40), YHOO: 39.21 (-0.03), LNKD: 224.10 (-0.70), IBM: 161.73 (+1.38), CMG: 725.94 (+0.12), STJ: 75.53 (-1.14), XLK: 42.59 (-0.09), THOR: 63.06 (-0.40), MSFT: 46.11 (+0.57), AAPL: 125.16 (-0.06), BHI: 59.26 (+0.98)
Robbins Arroyo LLP: Acquisition of Thoratec Corp. (THOR) by St. Jude Medical, Inc. (STJ) May Not Be in Shareholders' Best Interests
PR Newswire - Wed Jul 22, 1:21PM CDT
Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of Thoratec Corp. (NASDAQ: THOR) by St. Jude Medical, Inc. (NYSE: STJ). On July 22, 2015, the two companies announced the signing of a definitive merger agreement pursuant to which St. Jude will acquire Thoratec. Under the terms of the agreement, Thoratec shareholders will receive $63.50 for each share of Thoratec common stock.
STJ: 75.53 (-1.14), THOR: 63.06 (-0.40)
EQUITY ALERT: The Rosen Law Firm Announces Investigation of Thoratec Corp. Concerning its Proposed Sale to St. Jude Medical Inc. - THOR
Business Wire - Wed Jul 22, 12:23PM CDT
The Rosen Law Firm, a global investor rights law firm, announces that it is investigating the Board of Directors of Thoratec Corp. (NASDAQ: THOR) for possible breaches of fiduciary duty and other violations of law by failing to adequately shop Thoratec to maximize shareholder value before agreeing to be acquired by St. Jude Medical Inc. (NASDAQ: STJ).
STJ: 75.53 (-1.14), THOR: 63.06 (-0.40)
Why Thoratec Corp.'s Shares Jumped Today
George Budwell, The Motley Fool - Motley Fool - Wed Jul 22, 11:41AM CDT
What : Shares of the medical device-maker for heart failure Thoratec rose by 10% today on exceptional volume after the company announced that it has agreed to a $3.4 billion buyout offer from St. Jude Medical . Digging into the details, St. Jude...
STJ: 75.53 (-1.14), THOR: 63.06 (-0.40)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Thoratec Corp. of Commencement of an Investigation Concerning the Fairness of the Sale of the Company to St. Jude Medical, Inc.
Business Wire - Wed Jul 22, 10:23AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
STJ: 75.53 (-1.14), THOR: 63.06 (-0.40)
Stocks Fall Back as Crude Oil Dips Below $50
at The Street - Wed Jul 22, 9:53AM CDT
Stocks return to near session lows on Wednesday morning as crude oil dips below $50 a barrel on the back of a rise in weekly inventories.
KO: 40.84 (-0.06), GPRO: 63.95 (+2.27), BA: 146.11 (-0.36), T: 33.93 (-0.34), YHOO: 39.21 (-0.03), CMG: 725.94 (+0.12), DTV: 92.19 (-0.64), STJ: 75.53 (-1.14), THOR: 63.06 (-0.40), MSFT: 46.11 (+0.57), AAPL: 125.16 (-0.06)
St. Jude Medical Nabs Thoratec, Beats Q2 Estimates
at Investor's Business Daily - Wed Jul 22, 9:28AM CDT
Device giant St. Jude Medical (STJ) on Wednesday beat Q2 estimates and announced that it's acquiring Thoratec (THOR) for $3.4 billion, sending the latter's stock to a new high. Rumors that St. Jude and Thoratec were talking drove Thoratec's stock up...
STJ: 75.53 (-1.14), THOR: 63.06 (-0.40), HTWR: 85.63 (-2.58)
Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Thoratec Corporation Concerning its Proposed Sale to St. Jude Medical Inc.
PR Newswire - Wed Jul 22, 9:26AM CDT
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against the Board of Directors of Thoratec Corporation ("Thoratec" or the "Company"
(NasdaqGS:THOR) related to the proposed acquisition of the Company by St. Jude Medical Inc. The transaction is valued at around $3.4 Billion or $63.50 per share. STJ: 75.53 (-1.14), THOR: 63.06 (-0.40)
St. Jude Tops Q2 Earnings, Sales; Set to Acquire Thoratec - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 22, 9:17AM CDT
St. Jude Medical Inc (STJ) reported adjusted earnings of $1.03 in second-quarter 2015 which beat the Zacks Consensus Estimate by 4 cents.
STJ: 75.53 (-1.14), THOR: 63.06 (-0.40), RMTI: 15.99 (-0.74), NUVA: 49.64 (+0.05)
